<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04091997</url>
  </required_header>
  <id_info>
    <org_study_id>fayoum UH</org_study_id>
    <nct_id>NCT04091997</nct_id>
  </id_info>
  <brief_title>Macrophage Migration Inhibitory Factor for Diagnosing Endometriosis and Its Severity</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometriosis is a chronic disease affecting women of reproductive age. Macrophage migration
      inhibitory factor (MIF) is one of non-invasive blood biomarker that was detected in sera of
      endometriotic patients.The aim of this study was to evaluate the value of serum macrophage
      migration inhibitory factor in diagnosing endometriosis in women with infertility and chronic
      pelvic pain and correlate its level with the stage of the disease. Three hundred patient
      candidate for diagnostic laparoscopy were included in a case-control observational study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      observational case-control study conducted in Fayoum University hospital from March 2016 till
      September 2018. Three hundred women candidate for diagnostic laparoscopy for either
      infertility or gynecologic chronic pelvic pain were included. The study group included
      patients with diagnostic criteria of endometriosis. The control group included other causes
      of infertility or pelvic pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">September 2018</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>level of serum macrophage migration inhibitory factor and stage of the disease</measure>
    <time_frame>one year</time_frame>
    <description>serum MIF is a promising marker for noninvasive diagnosis of severity of endometriosis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>endometriosis</arm_group_label>
    <description>laparoscopy and directed biopsy of lesions serum macrophage migration inhibitory factor ELIZA assay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>diagnostic laparoscopy serum macrophage migration inhibitory factor ELIZA assay</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>serum Eliza assay</intervention_name>
    <description>laparoscopy and biopsy of lesions in endometriotic patients and seum ELIZA assay of microphage migration inhibitory factor</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>endometriosis</arm_group_label>
    <other_name>laparoscopy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Both groups were comparable regarding the baseline characteristics. these included age,
        parity, Body mass index, symptoms, type of infertility and chronic pelvic pain
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  postmenstrual women

          -  in childbearing period,

          -  presenting with either gynecologic chronic pelvic pain (CPP) or infertility

          -  indicated and fit for diagnostic laparoscopy.

          -  All women must have no hormonal treatment for the last 3 months and.

        Exclusion Criteria:

          -  Women with bleeding tendency,

          -  suspicious of gynecologic malignancy or

          -  active infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>September 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University Hospital</investigator_affiliation>
    <investigator_full_name>Sahar MY Elbaradie</investigator_full_name>
    <investigator_title>associate Professor</investigator_title>
  </responsible_party>
  <keyword>Macrophage migration inhibitory factor</keyword>
  <keyword>Endometriosis</keyword>
  <keyword>Laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

